Ten serum-derived exosomal proteins were screened as potential biomarkers for HCC; the expression of six of these was downregulated (including FGA, FGB, and FGG) at the protein level, which was verified at the gene expression level through GEPIA (52), which is consistent with the current findings. This evidence concerns the gene FGB and hepatocellular carcinoma.